Cargando…
CalliSpheres(®) microsphere transarterial chemoembolization combined with (125)I brachytherapy for patients with non–small‐cell lung cancer liver metastases
OBJECTIVE: Poor prognosis and limited treatments of liver metastases from non–small‐cell lung cancer (NSCLC) after radical surgery are critical issues. The current study aimed to evaluate the efficacy and safety of CalliSpheres(®) microsphere transarterial chemoembolization (CSM-TACE) plus (125)I br...
Autores principales: | Zhao, Guangsheng, Liu, Song, Liu, Ying, Li, Xiang, Yu, Guangji, Zhang, Yuewei, Bian, Jie, Wu, Jianlin, Zhou, Jun, Gao, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413194/ https://www.ncbi.nlm.nih.gov/pubmed/36033546 http://dx.doi.org/10.3389/fonc.2022.882061 |
Ejemplares similares
-
Efficacy and safety of transarterial chemoembolization with CalliSpheres® Microspheres in head and neck cancer
por: Gao, Fei, et al.
Publicado: (2022) -
Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(®) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
por: Liang, Bin, et al.
Publicado: (2021) -
Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients
por: Zhao, Guangsheng, et al.
Publicado: (2021) -
Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres(®) Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
por: Duan, Xuhua, et al.
Publicado: (2022) -
Initial experience of drug-eluting bead transarterial chemoembolization with CalliSpheres(®) microspheres in treating liver metastases patients
por: Zhang, Guangqiang, et al.
Publicado: (2020)